LSV Asset Management lessened its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 5.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 6,782,101 shares of the biotechnology company’s stock after selling 382,108 shares during the period. LSV Asset Management owned 4.34% of Ironwood Pharmaceuticals […]
GW Henssler & Associates Ltd. decreased its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 28.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,821 shares of the biotechnology company’s stock after selling 5,500 shares during the period. GW Henssler & Associates Ltd.’s […]
Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) fell 2.9% on Monday . The stock traded as low as $7.79 and last traded at $7.83. 449,404 shares traded hands during trading, a decline of 90% from the average session volume of 4,705,987 shares. The stock had previously closed at $8.06. Analyst Ratings Changes […]
China Universal Asset Management Co. Ltd. lifted its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 351.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 18,061 shares of the biotechnology company’s stock after purchasing an additional 14,064 shares during the quarter. […]
StockNews.com upgraded shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) from a hold rating to a buy rating in a report issued on Wednesday morning. Several other brokerages have also recently issued reports on IRWD. Jefferies Financial Group began coverage on shares of Ironwood Pharmaceuticals in a research report on Thursday, November 9th. They issued […]